ReportsnReports | Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018 GlobalData, the industry analysis specialist, has released its new report, “Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018�.
The report is an essential source of information and analysis on the global Autistic Disorder Therapeutics market. The report identifies the key trends shaping and driving the global Autistic Disorder Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Autistic Disorder Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by GlobalData’s team of industry experts. Browse All : Market Research Reports Scope : The report provides information on the key drivers and challenges of the Autistic Disorder Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Autistic Disorder Therapeutics market revenues data from 2005 to 2010, forecast for eight years to 2018. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Autistic Disorder Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Autistic Disorder Therapeutics market. - Analysis of key recent licensing and partnership agreements in Autistic Disorder Therapeutics market Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Autistic Disorder Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and
companies likely to impact the global Autistic Disorder Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Autistic Disorder Therapeutics market landscape? – Identify, understand and capitalize. Table of Contents 1 Table of Contents 3 1.1 List of Tables 5 1.2 List of Figures 6 2 Autism Spectrum Disorder (ASD) Therapeutics: Introduction 7 2.1 Disease Overview 7 2.1.1 Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) Classification for ASD: 7 2.2 Epidemiology 8 2.2.1 Worldwide Prevalence 8 2.2.2 Trends 8 2.2.3 Gender Ratio 8 2.2.4 Co-morbidity 8 2.2.5 Quality of Life (QoL) 9 2.2.6 Funding 9 2.2.7 Economic Burden 9 2.3 Etiology and Pathophysiology 9 2.4 Signs and Symptoms 10 2.5 Diagnosis 12 2.5.1 Diagnosis of ASD Based on DSM-IV Classification: 12 2.6 Treatment and Management Options 14 2.7 Referral Pathway 16 2.8 GlobalData Pipeline Report Guidance 17 3 ASD Therapeutics: Market Characterization 18 3.1 ASD Therapeutics Market Size (2005-2010) - Global 18 3.2 ASD Therapeutics Market Forecast (2010-2018) - Global 19 3.3 ASD Therapeutics Market Size (2005-2010) - The US 20 3.4 ASD Therapeutics Market Forecast (2010-2018) - The US 21 3.5 ASD Therapeutics Market Size (2005-2010) - France 22 3.6 ASD Therapeutics Market Forecast (2010-2018) - France 23 3.7 ASD Therapeutics Market Size (2005-2010) - Germany 24
3.8 ASD Therapeutics Market Forecast (2010-2018) - Germany 25 3.9 ASD Therapeutics Market Size (2005-2010) - Italy 26 3.10 ASD Therapeutics Market Forecast (2010-2018) - Italy 27 3.11 ASD Therapeutics Market Size (2005-2010) - Spain 28 3.12 ASD Therapeutics Market Forecast (2010-2018) - Spain 29 3.13 ASD Therapeutics Market Size (2005-2010) - The UK 30 3.14 ASD Therapeutics Market Forecast (2010-2018) - The UK 31 3.15 ASD Therapeutics Market Size (2005-2010) - Japan 32 3.16 ASD Therapeutics Market Forecast (2010-2018) - Japan 33 3.17 Drivers and Barriers for the ASD Therapeutics Market 34 3.17.1 Drivers for the ASD Therapeutics Market 34 3.17.2 Barriers for the ASD Therapeutics Market 34 3.18 Opportunity and Unmet Need 35 3.19 Key Takeaway 36 4 ASD Therapeutics: Competitive Assessment 37 4.1 Overview 37 4.2 Strategic Competitor Assessment 37 4.3 Product Profiles for the Major Marketed Products in the ASD Therapeutics Market 38 4.3.1 Abilify (aripiprazole) 38 4.3.2 Risperidone 39 4.4 Key Takeaway 41 5 ASD Therapeutics: Pipeline Assessment 42 5.1 Overview 42 5.2 Strategic Pipeline Assessment 42 5.3 ASD Therapeutics Pipeline - Pipeline by Phases of Development 42 5.3.1 ASD Therapeutics - Phase III Pipeline 43 5.3.2 ASD Therapeutics - Phase II Pipeline 43 5.3.3 ASD Therapeutics - Phase I Pipeline 44 5.3.4 ASD Therapeutics Market - Pre-clinical Pipeline 44 5.3.5 Technology Trends Analytic Framework 44 5.4 ASD Therapeutics Market - Pipeline by Mechanism of Action 46 5.5 ASD Therapeutics - Promising Drugs under Clinical Development 47 5.6 Molecule Profile for Promising Drugs under Clinical Development 47 5.6.1 NPL-2008 47 5.6.2 CM-AT 48 5.7 Key Takeaway 49 6 ASD Therapeutics: Clinical Trials Mapping 50 6.1 Clinical Trials by Region/Country (The US, the EU and Japan) 50 6.2 Clinical Trials by Phase 51
6.3 Clinical Trials by Trial Status 52 6.4 Prominent Sponsors 53 6.5 Top Companies Participating in ASD Therapeutics Clinical Trials 55 7 Strategic Assessment 56 7.1 Key Events Impacting the Future Market 56 7.2 ASD Therapeutics: Implications for Future Market Competition 57 8 ASD Therapeutics: Future Players 58 8.1 Introduction 58 8.2 Company Profiles 59 8.2.1 Neuropharm Group PLC 59 8.2.2 Curemark LLC 59 8.2.3 Seaside Therapeutics 60 8.2.4 Cellceutix Corporation 60 9 ASD Therapeutics: Licensing and Partnership Deals 61 10 ASD Therapeutics: Appendix 62 10.1 Market Definitions 62 10.2 Abbreviations 62 10.3 Methodology 63 10.3.1 Coverage 63 10.3.2 Secondary Research 63 10.3.3 Forecasting 64 10.3.4 Primary Research 65 10.3.5 Expert Panel Validation 65 10.4 Contact Us 66 10.5 Disclaimer 66 10.6 Bibliography 66 Latest Market Research Reports: New Zealand Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices Oil & Gas Exploration In the Arctic Region - Analysis of Exploration & Development Plans in this Environmentally Sensitive Area Fiber Optic Sensors: Global Markets West Europe Beverage Forecasts About Us: ReportsnReports is an online library of over 75,000 market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Follow us on Twitter: http://twitter.com/marketsreports Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact: Mr. Priyank 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: + 1 888 391 5441 E-mail: sales@reportsandreports.com http://www.reportsnreports.com Visit Our Blog : Market Research Reports